Quantifying benefits and risks of vaccinating Australian children aged six months to four years with trivalent inactivated seasonal influenza vaccine in 2010.

MLA

Kelly, H., et al. “Quantifying Benefits and Risks of Vaccinating Australian Children Aged Six Months to Four Years with Trivalent Inactivated Seasonal Influenza Vaccine in 2010.” Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin, vol. 15, no. 37, Sept. 2010. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=20929647&authtype=sso&custid=ns315887.

APA

Kelly, H., Carcione, D., Dowse, G., & Effler, P. (2010). Quantifying benefits and risks of vaccinating Australian children aged six months to four years with trivalent inactivated seasonal influenza vaccine in 2010. Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin, 15(37).

Chicago

Kelly, H, D Carcione, G Dowse, and P Effler. 2010. “Quantifying Benefits and Risks of Vaccinating Australian Children Aged Six Months to Four Years with Trivalent Inactivated Seasonal Influenza Vaccine in 2010.” Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 15 (37). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=20929647&authtype=sso&custid=ns315887.